513 related articles for article (PubMed ID: 18522017)
1. [Creatine kinase increase under simvastatin--therapeutic consequences?].
Rasche-Schürmann CC; Picksak G; Stichtenoth DO
Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
[TBL] [Abstract][Full Text] [Related]
2. Managing statin myopathy.
Venero CV; Thompson PD
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
[TBL] [Abstract][Full Text] [Related]
3. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
[TBL] [Abstract][Full Text] [Related]
4. Muscle symptoms associated with statins: a series of twenty patients.
Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
[TBL] [Abstract][Full Text] [Related]
5. The risk for significant creatine kinase elevation with statins.
Stolcpart RS; Olson KL; Delate T; Rasmussen J; Rehring TF; Merenich JA
Am J Cardiovasc Drugs; 2010; 10(3):187-92. PubMed ID: 20524720
[TBL] [Abstract][Full Text] [Related]
6. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.
Golightly LK; Barber GR; Barron MA; Page RL
Drug Metabol Drug Interact; 2013; 28(1):49-58. PubMed ID: 23314530
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
8. Myopathy associated with atorvastatin-ezetimibe combination therapy.
Weffald LA; Flach LA
Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
[TBL] [Abstract][Full Text] [Related]
9. The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study.
Jasińska M; Owczarek J; Orszulak-Michalak D
Acta Pol Pharm; 2006; 63(5):386-90. PubMed ID: 17357590
[TBL] [Abstract][Full Text] [Related]
10. Muscle toxicity with statins.
Hedenmalm K; Alvan G; Ohagen P; Dahl ML
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
[TBL] [Abstract][Full Text] [Related]
11. Presymptomatic neuromuscular disorders disclosed following statin treatment.
Tsivgoulis G; Spengos K; Karandreas N; Panas M; Kladi A; Manta P
Arch Intern Med; 2006 Jul; 166(14):1519-24. PubMed ID: 16864763
[TBL] [Abstract][Full Text] [Related]
12. A case of asymptomatic cytoplasmic body myopathy revealed by sinvastatin.
Evangelista T; Ferro J; Pereira P; de Carvalho M
Neuromuscul Disord; 2009 Jan; 19(1):66-8. PubMed ID: 19084404
[TBL] [Abstract][Full Text] [Related]
13. Managing statin-induced muscle toxicity in a lipid clinic.
Blaier O; Lishner M; Elis A
J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
[TBL] [Abstract][Full Text] [Related]
14. [Myotoxicity and rhabdomyolisis due to statins].
Banga JD
Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
[TBL] [Abstract][Full Text] [Related]
15. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
Fung EC; Crook MA
Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
[TBL] [Abstract][Full Text] [Related]
16. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.
Trøseid M; Henriksen OA; Lindal S
APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940
[TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyolysis related to statin and seizures: report of 3 cases].
Guan YQ; Shi YJ; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1795-6. PubMed ID: 22027795
[TBL] [Abstract][Full Text] [Related]
18. Differential association between statin exposure and elevated levels of creatine kinase.
Chan J; Hui RL; Levin E
Ann Pharmacother; 2005 Oct; 39(10):1611-6. PubMed ID: 16160000
[TBL] [Abstract][Full Text] [Related]
19. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis.
Johnson JL; Loomis IB
Pharmacotherapy; 2006 Mar; 26(3):414-22. PubMed ID: 16503723
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition.
Hu M; Mak VW; Tomlinson B
J Clin Pharm Ther; 2011 Jun; 36(3):419-25. PubMed ID: 21545622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
